Dr. Sibley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Page Mill Road
Palo Alto, CA 94301
Summary
- Late stage drug development with broad clinical trial experience in academics, the public sector and biopharma
Education & Training
Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2005 - 2009
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2001 - 2005- Northwestern University The Feinberg School of MedicineClass of 2001
Certifications & Licensure
OR State Medical License 2013 - 2019
MD State Medical License Active through 2013
Clinical Trials
- A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism Start of enrollment: 2019 Aug 27
- A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism Start of enrollment: 2021 Feb 16
- High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly Start of enrollment: 2003 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 16 citationsEfficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.Aliya A Khan, Mishaela R Rubin, Peter Schwarz, Tamara Vokes, Dolores M Shoback
Journal of Bone and Mineral Research. 2023-01-01 - 428 citationsExtracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathologyMartin Ugander, Abiola J Oki, Li-Yueh Hsu, Peter Kellman, Andreas Greiser
European Heart Journal. 2012-05-01 - 23 citationsPrediction and classification of cardiovascular disease risk in older adults with diabetes.Kenneth J. Mukamal, Jorge R. Kizer, Luc Djoussé, Joachim H. Ix, Susan J. Zieman
Diabetologia. 2013-02-01
Authored Content
- Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular RiskNovember 2017
- Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular RiskNovember 2017
- Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular RiskNovember 2017
Research History
- Staff Clinician, NIHNIH Clinical Center, Nation Institute of Biomedical Imaging and Bioengineering2009 - 2013
Professional Memberships
- Member
Industry Relationships
- Medical Director, Clinical Development, Ascendis Pharma N/ATransCon PTH development program2020 - Present
- Principal Consultant, Great Point Health2017 - 2020
- Clinical Director, Merck & Co.2016 - 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
